Michael Gernert

16PUBLICATIONS
85CO-AUTHORS
Arts therapyHaematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Clinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 29, 2026
Association of an app-based intervention with improvements in mobility, trunk muscle strength and patient-reported disease activity in axial spondyloarthritis: a 24-week pre-post study.

|Mar 26, 2026
Multiomic and Longitudinal Dissection of Immune Dynamics Associated with Parkinsonism after Ciltacabtagene Autoleucel Therapy.

Sofie-Katrin Kadel, Lukas Scheller, Alexander M Leipold

|Dec 02, 2025
Clinical and immunological long-term outcomes after autologous hematopoietic stem cell transplantation in systemic sclerosis: a retrospective single-center experience.

Michael Gernert, Jörg Henes, Patrick-Pascal Strunz

|Jul 09, 2025
Comparison of T cell response to vaccination in rheumatic patients treated with Janus kinase inhibitors and TNF inhibitors.

Sebastian Hüper, Florian Eisele, Johannes Duell

|Apr 15, 2025
Janus kinase inhibitors show a longer drug survival than biologics in a real-world cohort of patients with rheumatoid arthritis - a retrospective analysis from the RHADAR database.

Linus Maximilian Risser, Torsten Witte, Matthias Englbrecht

|Dec 11, 2024
Clonal T cell populations scarcely impair patients with rheumatic diseases: a prospective long-term follow up study.

Michael Gernert, Tobias Müller, Lukas Schweiker

Pageof 3

Frequent Collaborators

12 joint publications

Patrick-Pascal Strunz

12 joint publications

Marc Schmalzing

9 joint publications

Matthias Fröhlich

5 joint publications

Hannah Labinsky